Skip to main content

STATE STREET CORP

Position in NBIX — Neurocrine Biosciences Inc

CIK 93751 BOSTON, MA

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$573,665,255
-$28,074,191 QoQ
Shares Held
4,354,526
+2.6% QoQ
Ownership
4.33%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 17.114331157972188.ToString("F0")% Shared 0.9183318689565753.ToString("F0")% None 81.96733697307124.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $7,512,717,333 across 54 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
4,354,526 $573,665,255

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $573,665,255 4,354,526
2025-12-31 $601,739,446 4,242,681
2025-09-30 $610,158,722 4,346,479
2025-06-30 $561,616,353 4,468,266
2025-03-31 $537,750,029 4,862,116
2024-12-31 $667,640,200 4,891,137
2024-12-31 $667,640,200 4,891,137
2024-09-30 $593,186,319 5,148,293
2024-06-30 $634,432,508 4,608,357
2024-03-31 $550,295,421 3,989,961
2023-12-31 $535,385,151 4,063,336
2023-09-30 $431,607,037 3,836,507
2023-06-30 $373,097,855 3,956,499
2023-03-31 $384,627,396 3,799,915
2022-12-31 $445,533,415 3,730,186
2022-09-30 $400,063,437 3,766,721
2022-06-30 $367,758,896 3,772,660
2022-03-31 $350,078,437 3,734,170
2021-12-31 $317,440,598 3,727,141
2021-09-30 $331,951,031 3,461,068
2021-06-30 $332,185,567 3,413,333
2021-03-31 $317,749,106 3,267,343
2020-12-31 $237,452,176 2,477,331
2020-09-30 $218,993,726 2,277,389
2020-06-30 $279,140,880 2,288,040
2020-03-31 $217,349,639 2,511,261